Belviq and Abdominal pain - a phase IV clinical study of FDA data

Summary:

Abdominal pain is reported as a side effect among people who take Belviq (lorcaserin hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Gablofen, and have Weight decreased.

The phase IV clinical study analyzes which people have Abdominal pain when taking Belviq. It is created by eHealthMe based on reports of 3,159 people who have side effects when taking Belviq from the FDA, and is updated regularly.

What is Belviq?

Belviq has active ingredients of lorcaserin hydrochloride. It is often used in weight loss. eHealthMe is studying from 3,179 Belviq users. Check the latest studies of Belviq.

What is Abdominal pain?

Abdominal pain is found to be associated with 3,226 drugs and 5,746 conditions by eHealthMe. Check the latest studies of Abdominal pain.

On Jul, 10, 2026

3,159 people reported to have side effects when taking Belviq.
Among them, 14 people (0.44%) have Abdominal pain.

Among these 14 people:

How long have people been on Belviq when they have Abdominal pain? *

What is the gender of people who have Abdominal pain when taking Belviq? *

female: 91.67 %
male: 8.33 %

What is the age of people who have Abdominal pain when taking Belviq? *

What are other drugs people take besides Belviq? *

What are other side effects people have besides Abdominal pain? *

Fall: 2 people, 14.29%
Procedural Vomiting: 2 people, 14.29%
Procedural Nausea: 2 people, 14.29%
Cerebrospinal Fluid Leakage: 2 people, 14.29%
Nausea (feeling of having an urge to vomit): 2 people, 14.29%
Musculoskeletal Chest Pain (pain in chest muscle or nerve or bones): 2 people, 14.29%
Death: 2 people, 14.29%
Implant Site Pain: 2 people, 14.29%
Hypertonia (abnormal increase in muscle tension and a reduced ability of a muscle to stretch): 2 people, 14.29%
Diarrhea: 2 people, 14.29%

What are the existing conditions these people have? *

Weight Decreased: 7 people, 50.00%
Withdrawal Syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance): 2 people, 14.29%
Spinal Cord Trauma: 2 people, 14.29%
Post Laminectomy Syndrome: 2 people, 14.29%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 2 people, 14.29%
Movement Disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness): 2 people, 14.29%
Cerebral Palsy: 2 people, 14.29%
Migraine (headache): 1 person, 7.14%
High Blood Pressure: 1 person, 7.14%
Birth Control: 1 person, 7.14%

* Approximation only. Some reports may have incomplete information.

Do you take Belviq and have Abdominal pain?

- Check whether Abdominal pain is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Belviq:

Belviq (3,179 reports)

Abdominal pain treatments and more:

Abdominal pain (286,410 reports)

Browse all side effects of Belviq:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Abdominal pain:

Abdominal pain (3,226 drugs)

Browse all the conditions that are associated with Abdominal pain:

Abdominal pain (5,746 conditions)

Related publications that referenced our studies

Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .
Bhuvan KC, ALrasheedy AA, Ibrahim MI, "A case report from Nepalese community pharmacy on levofloxacin induced severe abdominal pain", Saudi Pharmaceutical Journal, 2013 Jul .

How the study uses the data?

The study uses data from the FDA. It is based on lorcaserin hydrochloride (the active ingredients of Belviq) and Belviq (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.